Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

Share Price Information for Pod Point (PODP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.85
Bid: 23.85
Ask: 23.90
Change: 0.075 (0.32%)
Spread: 0.05 (0.21%)
Open: 22.70
High: 23.90
Low: 22.70
Prev. Close: 23.80
PODP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Mid-stabilisation Period Announcement

12 Nov 2021 07:00

RNS Number : 2122S
Merrill Lynch International
12 November 2021
 

12th November 2021

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

Pod Point Group Holdings plc

 

 

Mid-stabilisation Period Announcement

 

 

Further to the pre-stabilisation period announcement dated 04 November 2021, Merrill Lynch International (contact: Andrew Briscoe; telephone: +44 20 7995 3700) hereby gives notice that, during the period covered by this announcement, the Stabilisation Manager named below undertook stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) in relation to the offer of the following securities, as set out below.

 

 

Securities:

 

Issuer:

Pod Point Group Holdings plc (the "Company" or "Pod Point")

 

ISIN / SEDOL:

GB00BNDRD100 / BNDRD10

 

Guarantor

 

 

Aggregate nominal amount:

39,884,245 ordinary shares

 

Description:

Ordinary registered shares ("ORDs" or "Ordinary Shares") of the Issuer (ISIN: GB00BNDRD100)

 

Offer Size:

39,884,245 ordinary shares (excluding the overallotment option)

 

Offer Price:

225 pence per ordinary share

 

 

 

 

Stabilisation:

 

Stabilisation Manager:

Merrill Lynch International

 

 

For each of the dates during which stabilisation transactions were carried out during the period covered by this announcement, the aggregate [quantity / volume / number] and price range was as follows:

 

 

 

 

 

 

Stabilisation transaction[s]

 

Date

Aggregate (Quantity / volume / number)

Buy/Sell

Lowest Price

Highest Price

Currency

Stabilisation Trading Venue

04/11/2021

2,564,602

Buy

2.1000

2.2000

GBP

LONDON STOCK EXCHANGE (XLOM)

05/11/2021

1

Buy

2.1600

2.1600

GBP

LONDON STOCK EXCHANGE (XLOM)

08/11/2021

14,716

Buy

2.1800

2.1800

GBP

LONDON STOCK EXHANGE (XLOM)

11/11/2021

10,000

Buy

2.2500

2.2500

GBP

LONDON STOCK EXCHANGE (XLON)

 

 

 

Important Notice:

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAUUVNRASUAARA
12
Date   Source Headline
31st May 202411:53 amRNSDirector/PDMR Shareholding
30th Apr 202411:00 amRNSTotal Voting Rights
26th Apr 20242:29 pmRNSAnnual Report & Notice of AGM
19th Apr 202411:32 amRNSDirector/PDMR Shareholding
18th Apr 20247:00 amRNSPreliminary Results for FY2023
3rd Apr 20247:00 amRNSNotice of Results
3rd Apr 20247:00 amRNSChange of Joint Corporate Broker
2nd Apr 20249:00 amRNSEstablishment of Technology Committee
12th Mar 20249:00 amRNSChange of Registered Office
29th Feb 20248:33 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSCEO Appointment & Directorate Change
20th Feb 20247:00 amRNSTrading Update
14th Feb 202411:24 amRNSBlock Listing Application
31st Jan 202410:45 amRNSTotal Voting Rights
10th Jan 202410:07 amRNSDirector Declaration
8th Dec 20238:47 amRNSBlock listing Interim Review
20th Nov 20233:13 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update and Capital Markets Day
17th Aug 20232:29 pmRNSNotice of Capital Markets Day
10th Aug 20239:00 amRNSNew Contract Win
31st Jul 20237:00 amRNSHalf-year Report
28th Jul 20239:00 amRNSChange of Auditor
27th Jul 20234:11 pmRNSUpdated 2023 Guidance
6th Jul 20237:00 amRNSDirectorate Change
30th Jun 20239:00 amRNSNew Contract Win
28th Jun 20239:00 amRNSNew Contract Win
14th Jun 202310:10 amRNSResult of AGM
8th Jun 20239:14 amRNSBlock listing Interim Review
31st May 20239:29 amRNSDirector Declaration
25th May 20231:50 pmRNSDirector/PDMR Shareholding
28th Apr 20235:27 pmRNSAnnual Report & Notice of AGM
31st Mar 20233:47 pmRNSDirector/PDMR Shareholding
31st Mar 202310:24 amRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20231:37 pmRNSBlock Listing Application
17th Feb 20237:00 amRNSPreliminary Unaudited Results for FY2022
16th Feb 20239:58 amRNSBoard Committee Change
11th Jan 20237:00 amRNSCompany Secretary Change
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 202210:32 amRNSDirector/PDMR Shareholding
22nd Dec 20224:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSExercise of Options and Issue of Shares
9th Dec 20227:00 amRNSBlock listing Interim Review
5th Dec 20227:00 amRNSCFO Appointment
21st Nov 20227:00 amRNSTrading Statement
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.